Yamaguchi Syndrome is a Morphological Variant of Hypertrophic Cardiomyopathy
Yamaguchi syndrome (apical hypertrophic cardiomyopathy) is a specific anatomical subtype of HCM characterized by localized hypertrophy confined predominantly to the left ventricular apex, rather than a separate disease entity. 1, 2
Relationship to HCM
Yamaguchi syndrome represents one of the many morphological patterns that HCM can manifest. While classic HCM typically involves the basal anterior septum and anterior free wall, approximately one-third of HCM patients have largely segmental wall thickening involving only a small portion of the left ventricle 3, 4. Apical HCM is one such pattern where hypertrophy is localized to the distal LV apex.
Key Distinguishing Features
Anatomical characteristics:
- Apical wall thickness ≥15 mm (or <15 mm with apex:base wall thickness ratio >1 in some cases) 1
- Characteristic "ace-of-spades" or "spade-shaped" LV cavity configuration on imaging 5, 6, 7
- Systolic obliteration of the LV cavity at the apex 6
Electrocardiographic hallmark:
- Giant negative T-waves (>10 mm) in precordial leads V4-V6 1, 6, 7
- Deep T-wave inversions that can mimic acute coronary syndrome 6, 7, 8
Shared Pathophysiology with HCM
Yamaguchi syndrome shares the fundamental genetic and pathophysiologic substrate of HCM:
- Same genetic basis: Caused by autosomal dominant mutations in sarcomeric protein genes 3, 4, 9
- Same diagnostic framework: Diagnosed using the same criteria as other HCM variants—unexplained LV hypertrophy without another cardiac or systemic disease capable of producing that magnitude of hypertrophy 3, 10, 2
- Same underlying pathology: Myocyte disarray, cellular hypertrophy, and interstitial fibrosis 11
Clinical Implications
Prognosis considerations: The preponderance of evidence suggests that segmental wall thickening at the low end of the morphologic spectrum, including nonobstructive apical HCM, generally confers a favorable prognosis in the absence of other major risk factors 12. However, the coexistence of apical HCM with other conditions (such as myocardial bridging) may create a complex arrhythmogenic and ischemic substrate 5.
Diagnostic pitfall: Yamaguchi syndrome frequently mimics acute coronary syndrome due to ischemic-type chest pain and characteristic ECG changes 6, 7, 8. This can lead to unnecessary invasive procedures if not recognized. The key is recognizing the pattern of giant T-wave inversions combined with normal troponins and characteristic imaging findings 6, 7.
Management Approach
Management follows standard HCM principles 11:
- Beta-blockers as first-line therapy for symptom control
- Risk stratification for sudden cardiac death
- Family screening with ECG and echocardiography
- Avoidance of strenuous competitive activities
The critical distinction is anatomical location, not disease mechanism—Yamaguchi syndrome is HCM affecting the apex rather than a separate cardiomyopathy.